Avantax Planning Partners’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-500	Closed	-$43K	–	535
2018 Q3	$43K	Buy	+500	New	+$43K	﹤0.01%	521
2018 Q2	–	Sell	-52	Closed	-$4K	–	575
2018 Q1	$4K	Buy	+52	New	+$4K	﹤0.01%	1404